L’Oréal steps up its biotech business with Evolva collaboration


- Last updated on GMT

L’Oréal steps up its biotech business with Evolva collaboration

Related tags Biotechnology

French cosmetics maker L’Oréal has upped its biotechnology efforts by announcing it has signed a collaboration agreement with Evolva Holding for the co-development of novel biosynthetic production routes for an undisclosed ingredient with broad applications in the cosmetics industry. 

Evolva is a pioneer in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition, with a portfolio that includes stevia, vanilla, saffron and resveratrol.

As well as developing its own proprietary ingredients, the Switzerland-headquartered firm also deploys its technology for partners.

Technology platform

Evolva and L’Oréal will apply Evolva’s fermentation technology platform to develop and optimise yeast strains for the sustainable, cost-effective production of this strategically important cosmetics ingredient.

Luc Aguilar, Global Head of L’Oréal’s Biotechnologies Department, says “Evolva’s biotech platform on yeast design, optimisation and fermentation could end in new cosmetic ingredients bringing a real breakthrough for our customers”.

Evolva CEO Neil Goldsmith adds that this collaboration further validates the broad industry applications potential of his company’s technology platform with products already featured in the health, wellness, and nutrition markets; and now cosmetics.

Ingredient agreement

“We look forward to working with L’Oréal. We are confident that together we can leverage new and sustainable production routes to improve this ingredient’s sustainability profile, reduce its production costs, improve its supply chain predictability, and increase its formulation flexibility in cosmetics,”​ he says.

The collaboration will begin immediately and conclude in late 2016, and includes an option to expand the ingredient focus.

L’Oréal will pay Evolva research fees during the project period, and additionally, Evolva will be eligible to receive milestone payments based on achieving research objectives.

Related news

Show more

Related products

Organic S. boulardii: A Probiotic Breakthrough by Lallemand

Organic S. boulardii: A Probiotic Breakthrough by Lallemand

Lallemand Health Solutions. Quality Probiotics. Complete Solutions. | 13-Feb-2023 | Infographic

Lallemand Health Solutions is launching the first and unique organic version of probiotic yeast Saccharomyces boulardii to mark the hundredth anniversary...

Related suppliers

Follow us


View more